Immuneering

+$0.44 (+11.31%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuneering and other ETFs, options, and stocks.

About IMRX

Immuneering Corp. engages in the development of new medicines which are unlikely to be found by traditional drug discovery methods. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis.

CEO
Benjamin J. Zeskind
Employees
64
Headquarters
Cambridge, Massachusetts
Founded
2008

IMRX Key Statistics

Market cap
114.25M
Price-Earnings ratio
—
Dividend yield
—
Average volume
83.46K
High today
$4.50
Low today
$3.75
Open price
$3.92
Volume
113.86K
52 Week high
$33.99
52 Week low
$3.74

IMRX Earnings

-$1.61
-$1.07
-$0.54
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Sep 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure